Patents by Inventor Krishnan M. Dhandapani

Krishnan M. Dhandapani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240131042
    Abstract: A method of reducing symptoms of a neurodegenerative disease comprising administering an effective amount of cannabidiol to a subject in need thereof to improved cognitive function and ameliorated the pathophysiology of the neurodegenerative disease.
    Type: Application
    Filed: February 16, 2022
    Publication date: April 25, 2024
    Applicant: AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
    Inventors: Babak BABAN, Jack YU, Krishnan M. DHANDAPANI
  • Publication number: 20230338396
    Abstract: Compositions and methods for treating or reducing symptoms of COVID-19 are provided herein. An exemplary method includes administering to the subject an effective amount of cannabidiol to reduce acute respiratory distress syndrome caused by COVID-19.
    Type: Application
    Filed: May 14, 2021
    Publication date: October 26, 2023
    Applicant: AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
    Inventors: Babak BABAN, Krishnan M. DHANDAPANI, Jack YU
  • Patent number: 9371263
    Abstract: Disclosed herein are compounds, compositions and methods for preventing and treating diseases such as intracerebral hemorrhage, cancer, or conditions associated with damaged cells, activated lymphocytes, or microbial products. The disclosed compounds are curcumin analogs. The curcumin analogs possess anti-inflammatory and antioxidant properties, which in part, reduce AP-1 and NF-?B activity.
    Type: Grant
    Filed: September 22, 2014
    Date of Patent: June 21, 2016
    Assignees: Augusta University Research Institute, Inc., East China Normal University
    Inventors: Cargill H. Alleyne, Jr., Krishnan M. Dhandapani, Ken Wen, MingLiang Ma, WenJing Hu
  • Publication number: 20150087705
    Abstract: Disclosed herein are compounds, compositions and methods for preventing and treating diseases such as intracerebral hemorrhage, cancer, or conditions associated with damaged cells, activated lymphocytes, or microbial products. The disclosed compounds are curcumin analogs. The curcumin analogs possess anti-inflammatory and antioxidant properties, which in part, reduce AP-1 and NF-?B activity.
    Type: Application
    Filed: September 22, 2014
    Publication date: March 26, 2015
    Inventors: Cargill H. Alleyne, JR., Krishnan M. Dhandapani, Ken Wen, MingLiang Ma, WenJing Hu